Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boulder, Colorado
- Most recent report
- 10-Q, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 418 filings
- On EDGAR
- CIK 1710072
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 22
News 8 of 50
- 8-K Quarterly results Aug 6, 2026
- 8-K/A Current report on a material event, amended Jul 16, 2026
- 8-K Acquisition or disposal closed Jul 13, 2026
- 8-K Shareholder vote results Jun 5, 2026
- 8-K Significant contract Jun 1, 2026
- 8-K Quarterly results May 7, 2026
- 8-K Quarterly results Feb 26, 2026
- 8-K Leadership change Nov 20, 2025
Prospectuses and Registrations 8 of 20
- S-8 Registration statement for an employee plan May 7, 2026
- 424B5 Prospectus supplement for an offering Apr 2, 2025
- S-8 Registration statement for an employee plan Mar 3, 2025
- S-8 Registration statement for an employee plan Nov 7, 2024
- S-3ASR Automatic shelf registration May 10, 2024
- S-8 Registration statement for an employee plan May 9, 2024
- 424B5 Prospectus supplement for an offering Jan 19, 2024
- 424B3 Prospectus supplement for an offering Jan 19, 2024
Proxies 8 of 13
- DEFA14A Extra proxy material Apr 23, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2026
- DEFA14A Extra proxy material May 14, 2025
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- DEFA14A Extra proxy material May 7, 2024
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
Ownership 8 of 293
- 4/A Insider reported a trade, amended Aug 17, 2026
- 4/A Insider reported a trade, amended Aug 17, 2026
- 4/A Insider reported a trade, amended Aug 17, 2026
- 4/A Insider reported a trade, amended Aug 17, 2026
- 4/A Insider reported a trade, amended Aug 17, 2026
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
Other 8 of 20
- ARS Annual report sent to shareholders Apr 23, 2026
- S-3MEF Jan 19, 2024
- ARS Annual report sent to shareholders Apr 28, 2023
- EFFECT Notice that a registration became effective May 5, 2022
- CORRESP Reply to SEC staff May 3, 2022
- UPLOAD Comment letter from SEC staff Apr 8, 2022
- EFFECT Notice that a registration became effective Mar 25, 2021
- S-1MEF Mar 25, 2021
Everything here comes from Edgewise Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.